News

Deal Announcements

Adimab Adds $4 Million Venture Capital Investment

Thursday, December 2, 2010 5:31:00 AM PDT | VentureDeal Staff
Lebanon, New Hampshire  --  Biotechnology company Adimab has garnered $4 million in additional venture capital investment according to an SEC filing.

Adimab is developing a platform to minimize and potentially eliminate third-party royalties for antibody discovery.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1